FDA Import Refusal AEK-5713613-4/11/1 — Boehringer Ingelheim Pharmaceuticals, Inc.
The FDA refused shipment AEK-5713613-4/11/1 from Boehringer Ingelheim Pharmaceuticals, Inc. (United States) on Mar 26, 2019. The refused product falls under Drugs and Biologics — ANTI-DIABETIC N.E.C.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Mar 26, 2019
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY99 ANTI-DIABETIC N.E.C.
- Charges
- 75